Dueñas CK, Múnera-Echeverri AG, Muñoz-Ortiz E, Luiza-de CM, Guerrero M

Idioma: Inglés [English version]
Referencias bibliográficas: 10
Paginas: s480-483
Archivo PDF: 171.13 Kb.

REFERENCIAS (EN ESTE ARTÍCULO)

1. DesJardin JT, Chikwe J, Hahn RT, Hung JW, Delling FN. Sex differences and similarities in valvular heart disease. Circ Res. 2022; 130: 455-473.

2. Fleury M-A, Clavel M-A, Sex and race differences in the pathophysiology, diagnosis, treatment, and outcomes of valvular heart disease. Can J Cardiol. 2021; 37: 980-991.

3. Passos LSA, Jha PK, Becker-Greene D, Blaser MC. Romero D, Lupieri AL et al. Prothymosin alpha: A novel contributor to estradiol receptor alpha–mediated CD8+ T-cell pathogenic responses and recognition of type 1 collagen in rheumatic heart valve disease. Circulation. 2022; 145: 531-548.

4. Petersen SE, Khanji MY, Plein S, Lancellotti P, Bucciarelli-Ducci C. European Association of Cardiovascular Imaging expert consensus paper: a comprehensive review of cardiovascular magnetic resonance normal values of cardiac chamber size and aortic root in adults and recommendations for grading severity. Eur Heart J Cardiovasc Imaging. 2019; 20: 1321-1331.

5. Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015; 28: 1-39. e14.

6. Onorati F, D'Errigo P, Barbanti M, Rosato S, Covello RD, Maraschini A et al. Different impact of sex on baseline characteristics and major periprocedural outcomes of transcatheter and surgical aortic valve interventions: results of the multicenter Italian OBSERVANT Registry. J Thorac Cardiovasc Surg. 2014; 147: 1529-1539.

7. Vahanian A, Beyersdorf F, Praz F, Milojevic M, Baldus S, Bauersachs J et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease: Developed by the Task Force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2022; 43: 561-632.

8. Tarasoutchi F, Westerlund Montera M, de Oliveira Ramos AI, Sampaio RO, Egypto Rosa VE, Duenhas Accors TA et al. Update of the Brazilian guidelines for valvular heart disease. 2020. Arq Bras Cardiol. 2020; 115: 720-775.

9. Regitz-Zagrosek V, Roos-Hesselink JW, Baursachs J, Blomstrom-Lundqvist C, Cifkova R, De Bonis M et al. 2018 ESC guidelines for the management of cardiovascular diseases during pregnancy: the task force for the management of cardiovascular diseases during pregnancy of the European Society of Cardiology (ESC). Eur Heart J. 2018; 39: 3165-3241.

10. Muñoz-Ortiz E, Velásquez-Penagos J, Gándara-Ricardo J, Holguín E, Peláez M, Betancur-Pizarro AM et al. Anticoagulación en embarazadas con válvula mecánica cardíaca: reto clínico para el equilibrio materno y fetal. Ginecol Obstet Mex. 2021; 89: 43-50.